| Catheter (116) |  |
| Endoscope (33) | |
| Hearing aid (42) | |
| Hemostat (13) | |
| Medical instrument (8) | |
| Operating table (6) | |
| Pacemaker (46) | |
| Prosthesis (99) | |
| Stethoscope (6) | |
| Surgical instrument (9) | |
| Syringe (81) | |
| Wheelchair (33) | |
| Catheter (116) | |
| Endoscope (33) | |
| Hearing aid (42) | |
| Hemostat (13) | |
| Medical instrument (8) | |
| Operating table (6) | |
| Pacemaker (46) | |
| Prosthesis (99) | |
| Stethoscope (6) | |
| Surgical instrument (9) | |
| Syringe (81) | |
| Wheelchair (33) | |
"Our material's combination of injectability, rapid mechanical recovery, physiological stability and the ability to promote coagulation result in a hemostat for treating incompressible wounds in out-of-hospital, emergency situations,
It has been used in various therapies as a way to remove excess fibrin proteins from the blood to treat thrombosis and as a topical hemostat.
the hydrogel without batroxobin, the batroxobin without the hydrogel, a current clinical hemostat known as Gelfoam and an alternative self-assembling hemostat known as Puramatrix and found that none were as effective, especially in the presence of anticoagulants.
It has been used in various therapies as a way to remove excess fibrin proteins from the blood to treat thrombosis and as a topical hemostat.
the hydrogel without batroxobin, the batroxobin without the hydrogel, a current clinical hemostat known as Gelfoam and an alternative self-assembling hemostat known as Puramatrix and found that none were as effective, especially in the presence of anticoagulants.
It has been used in various therapies as a way to remove excess fibrin proteins from the blood to treat thrombosis and as a topical hemostat.
the hydrogel without batroxobin, the batroxobin without the hydrogel, a current clinical hemostat known as Gelfoam and an alternative self-assembling hemostat known as Puramatrix and found that none were as effective, especially in the presence of anticoagulants.
It has been used in various therapies as a way to remove excess fibrin proteins from the blood to treat thrombosis and as a topical hemostat.
the hydrogel without batroxobin, the batroxobin without the hydrogel, a current clinical hemostat known as Gelfoam and an alternative self-assembling hemostat known as Puramatrix and found that none were as effective, especially in the presence of anticoagulants.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011